About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

B-164031(2) 1 (1974-02-15)

handle is hein.gao/gaobaagre0001 and id is 1 raw text is: 



                      UNITED STATES GENERAL ACCOUNTING OFFICE
     lou                       WASHINGTON, D.C. 20548

MANPOWER AND WELFARE                                          F14b  Is 7y
      DIVISION

        B-164031 ( 2                                         F   1  74



        The Honorable                                               LM096755
        The Secretary of Health,
          Education, and Welfare

       Dear Mr. Secretary:

            During our survey of the administration of the fttqaid drug
        prgsjrz&, we found that the three States included in the survey
        (California, Ohio, and Texas) were expending significant amounts
        of f uds(port9,tionsof which, a.re rmbrs-ed~bytheFedera-evern-
        Mewtt) for prescription drugs that have been declared ineffective
        or possibly effective by the Food and Drug Administration (FDA).
        The Department of Health, Education, and Welfare (HEW) has not
        issued regulations prohibiting the us ,,ofEedera-,unds..for .the
        purchase fJ'nef.fec'tivandpossibly effective drugs under_he
        ed.cal-dprogram,. We believe that HEW should expedite the
        issuance of such regulations.

        BACKGROUND

            The 1962 Amendments (P.L. 87-781) to the Federal Food, Drug and
       Cosmetic Act required that drugs be effective before they can be
       approved for marketing. Under these amendments, FDA began evaluat-
       ing the effectiveness of all drugs that it had approved for market-
       ing under a safety criteria in force before the amendments. After
       analysis by the National Academy of Sciences/National Research
       Council of the available data relating to the effectiveness of a
       drug, FDA publishes in the Federal Register a notice of its initial
       classification of the drug as being effective, probably effective,
       possibly effective, or ineffective.

             If a drug is not classified as effective, a notice of an
       opportunity for a hearing is also published. If interested parties
       justify, on the basis of new evidence, the need for a hearing, one
       is held. After the hearings FDA publishes its final determination
       of the effectiveness of the drug and declares it to be either
       effective or ineffective.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most